First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors

Abstract

Although non-functioning pituitary tumors are frequent, diagnostic and therapeutic concepts are not well standardized. We here present the first German multidisciplinary guideline on this topic. The single most important message is to manage the patients by a multidisciplinary team (consisting at least of an endocrinologist, a neurosurgeon, and a (neuro-) radiologist). The initial diagnostic work-up comprises a detailed characterization of both biochemical (focusing on hormonal excess or deficiency states) and morphological aspects (with magnetic resonance imaging of the sellar region). An ophthalmological examination is only needed in presence of symptoms or large tumors affecting the visual system. Asymptomatic, hormonally inactive tumors allow for a 'wait and scan' strategy. In contrast, surgical treatment by an experienced pituitary surgeon is standard of care in case of (impending) visual impairment. Therapeutic options for incompletely resected or recurrent tumors include re-operation, radiotherapy, and observation; the individual treatment plan should be developed multidisciplinary. Irrespective of the therapeutic approach applied, patients require long-term follow-up. Patient with larger pituitary tumors or former surgery/radiotherapy should be regularly counseled regarding potential symptoms of hormonal deficiency states.

Key words

Adenoma - endocrinology - hormonally inactive - hormones - imaging - neuropathology - neuroradiology - neurosurgery - NFA - pathology - radiology - radiotherapy - recommendation - surgery - sellar mass - treatment.

Publication History

Received: 23 January 2021
Received: 23 January 2021

Accepted: 25 January 2021

Article published online:
09 March 2021

• References

• 1 Alexander EK, Pearce EN, Brent GA. et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. 2017; Thyroid 27: 315-389
• 2 American College of O, Gynecologists' Committee on Obstetric P Committee OpinionSummary: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol 2016; 127: 418
• 3 Casanueva FF, Molitch ME, Schlechte JA. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006; 65: 265-273
• 4 De Groot L, Abalovich M, Alexander EK. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 2543-2565
• 5 Fleseriu M, Bodach ME, Tumialan LM. et al. Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E527-E529
• 6 Freda PU, Beckers AM, Katznelson L. et al. Pituitary incidentaloma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 894-904
• 7 Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery: Guidelines for perioperative assessment and management. J Clin Endocrinol Metab 2002; 87: 2745-2750
• 8 Katznelson L, Laws ER, Melmed S. et al. Acromegaly: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 3933-3951
• 9 Kuo JS, Barkhoudarian G, Farrell CJ. et al. Congress of neurological surgeons systematic review and evidence-based guideline on surgical techniques and technologies for the management of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E536-E538
• 10 Lucas JW, Bodach ME, Tumialan LM. et al. Congress of neurological surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E533-E535
• 11 Melmed S, Casanueva FF, Hoffman AR. et al. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273-288
• 12 Nieman LK, Biller BM, Findling JW. et al. The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
• 13 Raverot G, Burman P, McCormack A. et al. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 2018; 178: G1-G24
• 14 Nomikos P, Ladar C, Fahlbusch R. et al. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) 2004; 146: 27-35
• 15 Raverot G, Assie G, Cotton F. et al. 2015; Biological and radiological exploration and management of non-functioning pituitary adenoma. Ann Endocrinol (Paris) 76: 201-209
• 16 Chanson P, Raverot G, Castinetti F. et al. French Endocrinology Society non-functioning pituitary adenoma w-g 2015 Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris) 76: 239-247
• 17 Puataweepong P, Dhanachai M, Hansasuta A. et al. Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife(R) stereotactic radiosurgery. J Neurooncol 2018; 139: 679-688
• 18 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol 2016; 131: 803-820
• 19 Osamura R, Lopes MBS, Grossman A. et al. Tumours of the pituitary gland. In Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. 4 ed.. Heidelberg-Berlin: Springer; 2017
• 20 Ronchi CL, Peverelli E, Herterich S. et al. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol 2016; 174: 363-372
• 21 Sbiera S, Perez-Rivas LG, Taranets L. et al. Driver mutations in USP8 wild type Cushing's disease. Neuro Oncol. 2019;
• 22 Iacovazzo D, Hernandez-Ramirez LC, Korbonits M. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening. Expert Rev Endocrinol Metab 2017; 12: 143-153
• 23 Knappe UJ, Moskopp D, Gerlach R. et al. Consensus on Postoperative Recommendations After Transsphenoidal Surgery. Exp Clin Endocrinol Diabetes 2019; 127: 29-36
• 24 Arita K, Tominaga A, Sugiyama K. et al. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 2006; 104: 884-891
• 25 Irvine WJ, Barnes EW. Adrenocortical insufficiency. Clinics in Endocrinology and Metabolism 1972; 1: 549-594
• 26 Knowlton AI, Baer L. Cardiac failure in Addison's disease. Am J Med 1983; 74: 829-836
• 27 Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: Challenges in disease detection and treatment. Endocr Rev 2005; 26: 775-799
• 28 Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941; 2: 281-284
• 29 Gerlach R, Krause M, Seifert V. et al. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien) 2009; 151: 873-900 Discussion 900